Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
The safety of rosiglitazone in the treatment of type 2 diabetes.
Thiazolidinediones and macular edema: comment on "Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes".
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA. 2007 Sep 12; 298(10):1189-95.
View in:
PubMed
subject areas
Cardiac Output, Low
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Myocardial Infarction
Randomized Controlled Trials as Topic
Risk
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH